These findings indicate that although total IgG levels are lower in CIS compared with HC, presumably reflecting IgG2 deficiency, the relative proportions of cells secreting IgG3 may be increased compared with those secreting IgG2 in MS. The gene discussed is IGHG3; the disease is in situ carcinoma.